跳至主要内容
临床试验/NCT05453266
NCT05453266已完成不适用

Arthroscopic Rotator Cuff Repair Performed With Intraarticular Tranexamic Acid. Could it Provide Improved Visual Clarity and Less Post-operative Pain? A Prospective, Double Blind, Randomized Study of 63 Patients

Florence Nightingale Hospital, Istanbul1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
63
试验地点
1
主要终点
Arthroscopic Visual Clarity

研究概览

简要总结

Shoulder arthroscopy is widely used for treatment of different shoulder pathologies. Visual clarity is essential for successful and safe surgery. The aim of present study is to determine whether intraarticular use of tranexamic acid (TXA) in surgery fluid can improve visual clarity and early postoperative pain.

详细描述

Patients and Methods After obtaining institutional review board approval (Istanbul Yeni Yuzyil University, Nr: 13.02.2020/009) together with the registry to ClinicalTrials.gov, patients were prospective enrolled in this observational study, which was designed as double-blind, placebo-controlled and randomized.

Inclusion criteria were defined as: being older than 18 years of age, having an MRI confirmed rotator cuff rupture with a history of failure of conservative treatment of at least 6 months, being willing to participate to the clinical trial.

Patient Selection Exclusion criteria were defined as: patients with a history of coagulopathy, deep venous thrombosis, tendency to thrombotic events, patients under anti-coagulant therapy, patients with inferior vena cava filter, patients with abnormal prothrombin time-activated partial thromboplastin time-bleeding time, patients with a history of cardiac/renal/hepatic disease, patients with a diagnosis of TXA allergy, patients with an acute RCT, having been treated conservatively for less than 6 months, being under the age of 18. Table 1.

As a result of the inclusion/exclusion criteria, 42 patients (14 had acute RCT, 12 were receiving anti-coagulant therapy, 9 had history of cardiac/hepatic/renal disease, 5 had abnormal PT-aPTT value at the time of the diagnosis, 2 had received conservative treatments for less than 6 months for RCR) were excluded from 105 patients, who were eligible and were willing to participate. The remaining 63 patients were enrolled in the study. Table 2 (Flowchart). All patients provided informed consents, so that their pre-operative, intra-operative and post-operative data including imaging studies and arthroscopic images could be used for publication by concealing their identity.

Randomization By using computer based randomization software acquired from random.org, patients were randomized into two groups comprising a TXA group (n=32, 24M, 8F) (TXA Group) and a control group (n=31, 22M,9F) (Control Group), while group information was neither shared with patients nor with the operating surgeon as a result of double-blind nature of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

性别
All
接受健康志愿者

入选标准

  • being older than 18 years of age,
  • having an MRI confirmed rotator cuff rupture with a history of failure of conservative treatment of at least 6 months,
  • being willing to participate to the clinical trial.

排除标准

  • patients with a history of coagulopathy, deep venous thrombosis, tendency to thrombotic events,
  • patients under anti-coagulant therapy,
  • patients with inferior vena cava filter,
  • patients with abnormal prothrombin time-activated partial thromboplastin time-bleeding time,
  • patients with a history of cardiac/renal/hepatic disease,
  • patients with a diagnosis of TXA allergy,
  • patients with an acute RCT, having been treated conservatively for less than 6 months,
  • being under the age of 18

结局指标

主要结局

Arthroscopic Visual Clarity

时间窗: Intra-operatively

Effect of TXA in arthroscopic irrigation solution to Arthroscopic Visual Clarity

次要结局

  • Post-operative Pain Evaluation(Up to the 2nd post-operative day)

研究者

发起方
Florence Nightingale Hospital, Istanbul
申办方类型
Other
责任方
Principal Investigator
主要研究者

Celaleddin BILDIK

Principal Investigator

Florence Nightingale Hospital, Istanbul

研究点 (1)

Loading locations...

相似试验